‘Bloody interesting companies’ deliver for Woodford
Immunocore leads trio of positive updates from the Patient Capital Trust
News
-
-
Six investors on how to play the Brexit deal chaos
Portfolio managers and analysts on whether beaten down stocks present buying opportunity
-
Natixis Investment Managers’ affiliates announce merger
Loomis Sayles and McDonnell Investment Management set to integrate in early 2019
-
Brexit chaos sparks interest in physical gold
Investors piling in at a rate not seen since EU referendum in 2016
-
Patisserie Valerie CEO resignation ‘no surprise’
Group saw shares suspended, a gaping black hole in finances and rescue rights issue
-
Polar Capital Japan manager heads to Paris office
Gerard Cawley is the only fund manager based in the European outpost
-
Buxton: Don’t be overinfluenced by every ‘twist and turn’ of Brexit saga
Two Cabinet resignations rock Theresa May as Brexit deal agreed
-
Tatton confirms M&A plans as profits up 454%
CEO says conversations with small DFMs and asset managers are underway
-
JPMAM appoints head of UK platforms
Viewed as important strategic hire by platform industry members
-
KW Wealth launches ethical portfolio range
Move comes despite limited number of suitable actively-managed fund choices
-
Women-only wealth manager network launches
Raymond James pushing to increase the number of females in wealth management
-
Nick Train: There is no bubble for central banks to burst
FTSE yield is high and capital gains meagre, says UK equity manager
